Delivery Order SPE2DB22D9367-SPE2DB24FSY94
Award Date
7/23/24
Potential Completion Date
8/13/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $24,095.76, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Alecensa 150mg capsules, with a performance period ending on September 14, 2023. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $62,371.45, is for the delivery of the pharmaceutical product Alecensa 150 mg capsules. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order contract is for the supply of Alecensa 150 mg capsules. The award is part of a larger indefinite delivery vehicle (IDV) contract, valued at up to $4,999,999, that DMS Pharmaceutical Group Inc. holds with the DLA under the SPE2DB program. This single-award IDV enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,897.20 contract is for the delivery of Alecensa 150 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
The federal contract award SPE2DX15D9168 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $96,383.04 firm fixed-price delivery order is for the supply of the prescription drug Alecensa 150 mg capsules, with a completion date of February 10, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,948.60 firm fixed-price delivery order contract is for the supply of the branded pharmaceutical product Alecensa 150 mg capsule, with an ultimate completion date of July 2, 2024. The contract is part of DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,474.29, is for the delivery of Alecensa 150 mg capsules and has an ultimate completion date of June 12, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
The federal contract award SPE2DB20D9226|SPE2DB25FQ55X was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order is for the supply of 4566278255 Alecensa 150 mg capsules. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,047.88, is for the delivery of the pharmaceutical product Alecensa 150 mg capsules. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $49,897.20 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Alecensa 150 mg capsules. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical...